Trials / Conditions / Relapsed/Refractory Leukemia
Relapsed/Refractory Leukemia
3 registered clinical trials studyying Relapsed/Refractory Leukemia — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy NCT06756321 | Affiliated Hospital of Nantong University | EARLY_Phase 1 |
| Terminated | Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory L NCT00780143 | PharmaMar | Phase 1 / Phase 2 |
| Terminated | Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL) NCT00724360 | Nantes University Hospital | Phase 2 |